Osteoarthritis Treatment: From Joint Preservation to Regenerative Therapies

Osteoarthritis treatment in Reston, Virginia, follows the same evidence-based ladder used across the US: exercise-based physical therapy, weight management and topical or oral NSAIDs come first, injections such as cortisone, hyaluronic acid or platelet-rich plasma (PRP) come next, and knee or hip replacement is reserved for end-stage joints. Exercise therapy reduced knee osteoarthritis pain by roughly 40% in a 2015 Cochrane review of 54 randomized trials led by Marlene Fransen [2], and the 2019 American College of Rheumatology and Arthritis Foundation guideline strongly recommends exercise, weight loss and NSAIDs while recommending against PRP and stem cell injections for knee and hip osteoarthritis [23].

Around Reston, these options are delivered by orthopedic surgeons, sports medicine physicians, physiatrists, rheumatologists and physical therapists across Fairfax and Loudoun counties and along the Dulles corridor. You can compare arthritis treatment clinics in Virginia on Regenerated.com, which is free for patients, and read the sections below to judge which step fits your joint.

Osteoarthritis Is Not Just “Wear and Tear”

For decades, doctors described osteoarthritis (OA) as a degenerative condition caused by mechanical wear on joint cartilage. That framing made it sound inevitable and irreversible, like brake pads grinding down. But research over the past two decades has fundamentally changed how we understand this disease.

OA is an active biological process. Yes, mechanical stress plays a role, but the real driver is chronic low-grade inflammation within the joint. Inflammatory cytokines like interleukin-1 beta (IL-1β) and tumor necrosis factor alpha (TNF-α) accelerate cartilage destruction by activating enzymes called matrix metalloproteinases (MMPs) that break down the collagen and proteoglycan matrix of cartilage [1]. The synovial membrane becomes inflamed, subchondral bone remodels, and osteophytes (bone spurs) form as the body tries to stabilize a joint that is losing structural integrity.

This distinction matters because it opens the door to treatments that target the underlying biology, not just the symptoms. If OA were purely mechanical, the only real options would be pain management and eventual surgery. Because it involves inflammation, immune signaling, and tissue remodeling, there are interventions that can genuinely slow or modify the disease process.

What Else Is Osteoarthritis Called, and How Is It Diagnosed?

Clinicians also call osteoarthritis degenerative joint disease (DJD) or osteoarthrosis, and knee and hip OA are sometimes written as gonarthrosis and coxarthrosis. It most often affects the knees, hips, hands and spine. It differs from rheumatoid arthritis, which is an autoimmune disease of the joint lining, a contrast covered in our comparison of osteoarthritis and rheumatoid arthritis.

The National Institute for Health and Care Excellence (NICE) advises diagnosing osteoarthritis clinically, without imaging, in people who are 45 or over, have activity-related joint pain, and have either no morning stiffness or stiffness lasting no longer than 30 minutes [24]. When X-rays are taken, clinicians often grade severity on the Kellgren-Lawrence (KL) scale from 0 to 4, and that grade shapes which treatments are likely to help, as the stepwise plan below shows. People with hip osteoarthritis and knee OA have the largest body of treatment trials behind them.

What Do Clinical Guidelines Recommend for Osteoarthritis?

The 2019 American College of Rheumatology (ACR) and Arthritis Foundation guideline, written by Sharon Kolasinski and colleagues, is the main US reference for treating hand, hip and knee osteoarthritis [23]. It strongly recommends exercise, weight loss for people with knee or hip OA who are overweight, self-management programs, tai chi, cane use, tibiofemoral knee bracing, topical NSAIDs for knee OA, oral NSAIDs and corticosteroid injections for knee OA.

The same guideline gives conditional recommendations for acetaminophen, duloxetine, tramadol, yoga, acupuncture, cognitive behavioral therapy and radiofrequency ablation for knee OA. It recommends against platelet-rich plasma and stem cell injections, which is why most PRP and stem cell treatment for OA in the US is delivered outside guideline-based care and paid for in cash.

The 2022 NICE guideline for England (NG226) names therapeutic exercise and weight management as the core treatments [24]. It advises against routinely offering paracetamol or weak opioids, does not recommend glucosamine, strong opioids or hyaluronic acid injections, and suggests corticosteroid injections when other medicines are ineffective or unsuitable. The American Academy of Orthopaedic Surgeons (2021) takes a softer line on PRP, rating evidence that it may reduce knee OA pain as limited. The gap between these bodies is the honest state of the science: regenerative injections are promising, but not settled.

Conventional Treatments: What Works and What Falls Short

Physical Therapy and Targeted Exercise

Physical therapy remains one of the most effective and underutilized osteoarthritis treatments. A 2015 meta-analysis of 54 randomized controlled trials found that exercise therapy reduced knee OA pain by roughly 40% and improved physical function by about 30%, effects comparable to many medications without the side effects [2].

The key is specificity. A good physical therapist will identify which muscles around the joint are weak or imbalanced, design a strengthening program to offload the damaged compartment, and teach movement patterns that reduce joint stress. For knee OA, quadriceps strengthening alone can dramatically reduce pain and improve function [3].

NSAIDs and Acetaminophen

Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen, naproxen, and celecoxib are the most commonly prescribed medications for OA. They reduce pain and inflammation, and they work, at least in the short term. The problem is long-term use. Chronic NSAID use increases risks of gastrointestinal bleeding, kidney damage, and cardiovascular events [4]. Topical NSAIDs (like diclofenac gel) offer a safer alternative for accessible joints like the knee and hand, delivering anti-inflammatory effects locally with less systemic exposure.

Acetaminophen (Tylenol) was once considered first-line for OA pain, but recent evidence shows it provides minimal benefit for osteoarthritis, only slightly better than placebo in most trials [5]. It also carries liver toxicity risk at higher doses.

Corticosteroid Injections

Cortisone shots provide rapid, potent anti-inflammatory relief inside the joint. A single injection can reduce pain for weeks to months. However, repeated corticosteroid injections may actually accelerate cartilage loss over time. A landmark 2017 randomized trial published in JAMA found that patients receiving cortisone injections every 3 months for 2 years had significantly greater cartilage volume loss compared to saline placebo injections [6].

This does not mean cortisone is always harmful. For acute flares or bridging to other treatments, a well-timed injection can be valuable. But the evidence argues against using them as a long-term management strategy, which unfortunately is exactly how many patients receive them. Our comparison of PRP and cortisone injections walks through how the two differ in speed and duration of relief.

Other Options Guidelines Support: Duloxetine, Bracing and Nerve Ablation

Duloxetine, an antidepressant that also dampens pain signaling in the spinal cord, carries a conditional ACR recommendation for osteoarthritis pain, especially when several joints hurt or NSAIDs are unsuitable [23]. Tramadol is conditionally recommended for short-term use, while stronger opioids are discouraged by both the ACR and NICE.

Mechanical support counts as treatment too. A cane held in the hand opposite the painful knee or hip, an unloader brace for knee OA in one compartment, and a thumb splint for base-of-thumb arthritis all carry ACR recommendations. For people with knee pain who are not ready for surgery, radiofrequency ablation of the genicular nerves, the small sensory nerves around the knee, is a conditionally recommended option that pain medicine physicians perform.

Joint Replacement Surgery

Total joint replacement (arthroplasty) remains the definitive treatment for end-stage OA. Modern knee and hip replacements have excellent outcomes: roughly 90-95% of patients report significant pain relief, and prosthetics now last 15-25 years in most cases [7]. For someone with bone-on-bone arthritis who has exhausted conservative measures, surgery can be transformative.

But surgery is a major procedure with real risks (infection, blood clots, implant loosening, persistent pain in a subset of patients). It also has a ceiling: prosthetic joints don’t function exactly like natural ones, and revision surgery, if needed later, is more complex. The goal of most regenerative approaches is to delay or avoid that threshold.

Regenerative Therapies: Targeting the Biology of OA

Regenerative injections for osteoarthritis use the body's own signaling, through platelets, cells or a mild irritant, to change the environment inside the joint. They are usually cash pay, most are used off label, and guidelines remain cautious, so the evidence for each one is described plainly below.

Platelet-Rich Plasma (PRP)

PRP involves drawing the patient’s blood, concentrating the platelets (which contain hundreds of growth factors), and injecting that concentrate directly into the arthritic joint. The growth factors in PRP, including platelet-derived growth factor (PDGF), transforming growth factor beta (TGF-β), and vascular endothelial growth factor (VEGF), promote tissue repair and modulate inflammation [8].

The clinical evidence for PRP in knee OA is now reasonably strong. A 2019 meta-analysis of 30 randomized controlled trials found that PRP injections significantly outperformed hyaluronic acid and corticosteroid injections for both pain relief and functional improvement at 6 and 12 months [9]. The benefits appear most robust in early to moderate OA (Kellgren-Lawrence grades 1-3); patients with severe, bone-on-bone disease tend to respond less well.

Not all PRP is created equal. Leukocyte-poor PRP (LP-PRP) appears to produce better results in joints than leukocyte-rich formulations, likely because the white blood cells in leukocyte-rich PRP can trigger additional inflammation [10]. The concentration of platelets, activation method, and number of injections also influence outcomes. This variability in preparation is one reason study results have been inconsistent.

The centrifuge systems that prepare PRP are cleared by the FDA as devices, but PRP is not an FDA-approved treatment for osteoarthritis, and most insurers treat knee PRP as out of pocket. Our PRP treatment guide explains preparation types, and the national list of clinics offering PRP injections shows who provides it near you.

Mesenchymal Stem Cell (MSC) Therapy

Stem cell therapy for osteoarthritis typically involves harvesting mesenchymal stem cells (or more accurately, mesenchymal stromal cells) from the patient’s bone marrow or adipose tissue, processing them, and injecting them into the joint. These cells don’t simply “rebuild” cartilage on their own. Instead, they release a complex mixture of anti-inflammatory cytokines, growth factors, and extracellular vesicles that modulate the joint environment [11].

Clinical trial data is growing. A 2020 systematic review of 36 clinical studies found that MSC injections generally improved pain and function in knee OA, with some studies showing evidence of cartilage regeneration on MRI [12]. However, the quality of evidence remains moderate, with significant variability in cell source, dose, processing methods, and outcome measures across studies.

Cost is a significant barrier. MSC procedures typically range from $3,000-$10,000 per joint and are rarely covered by insurance. Patients should be cautious of clinics making exaggerated claims, and should look for practitioners who use evidence-based protocols and can discuss realistic expectations.

Regulation matters here. The FDA’s 2020 consumer alert on regenerative medicine products states that no stem cell or exosome product has been approved to treat osteoarthritis or any other orthopedic condition [25]. Same-day procedures that use your own minimally processed bone marrow aspirate concentrate (BMAC) are a different category from expanded or donor-derived cell products, which belong in FDA-regulated trials. The stem cell therapy guide covers those categories, and the directory lists stem cell therapy providers by state.

Prolotherapy

Prolotherapy involves injecting an irritant solution (most commonly hypertonic dextrose, a concentrated sugar solution) into and around the joint to stimulate a controlled inflammatory healing response. The theory is that this controlled inflammation triggers the body’s repair mechanisms, strengthening ligaments and potentially stimulating cartilage repair [13].

Evidence for prolotherapy in OA is more limited than for PRP but still encouraging. A randomized controlled trial published in the Annals of Family Medicine found that dextrose prolotherapy produced clinically meaningful improvements in pain, function, and stiffness in knee OA patients that persisted at 1-year follow-up [14]. It is also considerably less expensive than PRP or stem cell treatments, making it an accessible option. Read more in the prolotherapy treatment guide or in our head-to-head look at prolotherapy versus PRP.

Hyaluronic Acid Injections (Viscosupplementation)

Hyaluronic acid (HA) is a naturally occurring component of synovial fluid. In OA joints, the concentration and molecular weight of HA decreases, reducing the fluid’s ability to lubricate and cushion the joint. Viscosupplementation aims to restore these properties [15].

The evidence for HA injections is mixed. Some meta-analyses show modest pain reduction compared to placebo, while others find minimal benefit. A Cochrane review found that HA injections provided a small but statistically significant improvement in pain for knee OA, roughly equivalent to NSAIDs [16]. Results seem to be better with higher molecular weight products and in patients with mild to moderate OA.

HA injections are FDA-approved, generally safe, and covered by some insurance plans. They may work best as part of a combined approach rather than a standalone treatment. NICE in England goes further and advises against offering them at all [24], which shows how small the measured benefit is.

Other Therapies Marketed for Arthritis

Clinics also offer ozone injections, low-level laser therapy (photobiomodulation), extracorporeal shockwave therapy and exosome products for arthritic joints. These rest on small trials or laboratory work, and none is an FDA-approved treatment for osteoarthritis. Our review of ozone therapy for arthritis shows how to weigh that kind of early evidence before paying for a course.

Osteoarthritis Treatments Compared: Evidence, Coverage and Fit

Exercise, weight loss and NSAIDs have the strongest evidence and the broadest guideline support for osteoarthritis. Injections help selected patients for months rather than years, and joint replacement is the most reliable option for end-stage disease. The table below summarizes the figures and sources already cited above.

Lifestyle Factors: The Foundation of OA Management

Weight Management

Excess body weight is one of the strongest modifiable risk factors for OA progression, particularly in weight-bearing joints. Every pound of body weight translates to roughly 3-6 pounds of force across the knee during walking [17]. A weight loss of just 10% of body weight has been shown to reduce knee pain by approximately 50% and significantly slow structural disease progression [18].

But weight affects OA through more than just mechanical load. Adipose tissue is metabolically active, producing inflammatory adipokines (like leptin and adiponectin) that directly contribute to cartilage degradation. This partly explains why obesity also increases OA risk in non-weight-bearing joints like the hands.

Anti-Inflammatory Diet

Dietary patterns that reduce systemic inflammation can influence OA symptoms and progression. The Mediterranean diet, rich in omega-3 fatty acids, polyphenols, and fiber while low in processed foods and refined sugars, has been associated with lower OA prevalence and reduced symptom severity in observational studies [19].

Specific nutrients with evidence for joint health include:

• Omega-3 fatty acids: Reduce synovial inflammation and may slow cartilage degradation. Found in fatty fish, walnuts, and flaxseed.
• Vitamin D: Deficiency is associated with faster OA progression. Testing and supplementation when deficient is reasonable.
• Curcumin (from turmeric): Multiple RCTs show anti-inflammatory effects comparable to ibuprofen for OA pain, particularly in bioavailable formulations [20].
• Collagen peptides: A 2019 meta-analysis found modest benefits for joint pain and function with daily collagen supplementation [21].

Glucosamine is the supplement patients ask about most, and it has the weakest support: the ACR guideline recommends against it for knee and hip OA, and NICE advises clinicians not to offer it [23][24].

Exercise as Medicine

This deserves emphasis because so many OA patients avoid exercise out of fear that movement will worsen their joints. The opposite is true. Articular cartilage has no blood supply; it depends on the pumping action of joint loading and unloading to receive nutrients from synovial fluid. A sedentary joint is a starving joint.

Research consistently shows that appropriate exercise does not accelerate cartilage loss and actually slows OA progression. A combination of strengthening, flexibility, and low-impact aerobic exercise produces the best results [22]. Swimming, cycling, walking, tai chi, and yoga all have evidence supporting their use in OA management. Our list of exercises for osteoarthritis sorts the movements that help from the ones that aggravate sore joints.

Building a Treatment Strategy: The Stepwise Approach

OA treatment should be tailored to disease severity, the specific joint involved, individual risk factors, and patient goals. A reasonable stepwise approach looks like this:

Stage 1: Mild OA (Kellgren-Lawrence 1-2)

• Weight optimization if overweight
• Structured exercise program (ideally with physical therapy guidance initially)
• Anti-inflammatory dietary changes
• Topical NSAIDs as needed
• Consider prolotherapy or PRP to slow progression

Stage 2: Moderate OA (Kellgren-Lawrence 2-3)

• All of the above, intensified
• PRP injection series (typically 1-3 injections)
• Hyaluronic acid injections
• Oral NSAIDs for flares (short courses)
• Bracing or orthotics to offload the affected compartment
• Consider MSC therapy

Stage 3: Severe OA (Kellgren-Lawrence 3-4)

• Regenerative options may still provide symptom relief but cartilage regeneration is less likely
• Cortisone for acute flares (judicious use)
• Serious discussion about surgical options
• Partial joint replacement may be appropriate for single-compartment disease
• Total joint replacement when function and quality of life are significantly impaired

The joint changes the plan as well as the grade. Knee OA has the most injection data, as our guide to knee osteoarthritis staging and treatment explains, while hand OA leans on splints, topical NSAIDs and hand therapy. When pain moves between several joints, the joint pain overview covers other causes worth ruling out first.

When Surgery Makes Sense

Surgery is not a failure. For patients with end-stage OA who have genuinely exhausted conservative and regenerative options, joint replacement can restore function and relieve pain in ways that no injection or supplement can match. The decision should be based on functional limitation and quality of life, not just imaging findings. Some patients with severe-looking X-rays function well, while others with moderate radiographic changes are significantly impaired.

Red flags that suggest surgery should be considered sooner rather than later include: night pain that consistently disrupts sleep, inability to walk more than a few blocks, significant joint deformity with instability, and failure of multiple conservative treatments over 6-12 months.

Surgery is a spectrum, not one operation. Younger, active patients with damage on one side of the knee may be offered a high tibial osteotomy, which realigns the leg to shift load, or a unicompartmental (partial) knee replacement. Total knee arthroplasty (TKA) and total hip arthroplasty (THA) are the standard operations for advanced disease, and an orthopedic surgeon is the clinician to assess which one fits.

Finding Osteoarthritis Treatment in Reston and Northern Virginia

Osteoarthritis treatment in Reston uses the same options described above, delivered through orthopedic, sports medicine, rheumatology, pain medicine and physical therapy practices across Northern Virginia. Reston sits in western Fairfax County along the Dulles Toll Road and the Metro Silver Line, so most residents can reach clinics in Reston, Herndon, Tysons, Fairfax and Loudoun County without a long drive.

Which Clinicians Treat Osteoarthritis Around Reston?

A primary care physician usually makes the diagnosis and starts exercise, weight and medication care. Physical therapists run the exercise programs that carry the strongest evidence. Sports medicine physicians and physiatrists (physical medicine and rehabilitation doctors) give most guided injections, including PRP. Rheumatologists help when the picture could be inflammatory arthritis, and orthopedic surgeons assess candidates for osteotomy or joint replacement.

How Do I Use the Clinic Directory for Reston?

Start with the Virginia arthritis treatment directory, or with the Virginia stem cell therapy listings if you are researching cell-based care. Patients who work in the District or cross the river can also compare PRP clinics in Washington, DC and arthritis treatment in Maryland.

Listing order on Regenerated.com is not a paid ranking. Featured slots are clearly labeled and capped in number. A Verified badge means the clinic completed credential checks, not that it spent more. The directory is free for patients, and being listed is not an endorsement. Our explainer on featured, verified and organic listings shows how each label is earned.

What Should I Ask Before a Regenerative Injection?

1. Which joint and Kellgren-Lawrence grade do you think I have, and does that grade match the patients in the studies you rely on?
2. What exactly will be injected: leukocyte-poor or leukocyte-rich PRP, dextrose, bone marrow concentrate or a donor product?
3. Will the injection be guided by ultrasound or fluoroscopy?
4. Is this product FDA-approved for osteoarthritis, or is it offered within a trial listed on ClinicalTrials.gov with FDA oversight?
5. What is the full price in writing, and does any part of it qualify for insurance?
6. How will you measure whether it worked, and what is the plan if it does not?

The Bottom Line

Osteoarthritis treatment has evolved dramatically. The old model of “take Advil until you need a joint replacement” has been replaced by a spectrum of options that can modify disease progression, reduce inflammation at its source, and help preserve joint function for longer. The most important factors are starting early, combining multiple approaches, maintaining a healthy weight, staying active, and working with practitioners who understand the full range of available therapies.

Regenerative medicine offers genuine promise for OA, particularly PRP and MSC therapy. But these are tools within a broader strategy, not magic bullets. The patients who do best are those who commit to the lifestyle foundations (exercise, diet, weight management) while using regenerative therapies to give their joints every biological advantage.

Whether you live in Reston or anywhere else in the US, the order stays the same: exercise, weight management and NSAIDs first, injections for selected joints, and joint replacement for end-stage disease. The national directory of arthritis treatment clinics and the arthritis treatment overview are good next steps once you know which step you are on.

Frequently Asked Questions About Osteoarthritis Treatment

Where can I get osteoarthritis treatment in Reston, VA?

Osteoarthritis treatment in Reston is available from physical therapists, sports medicine physicians, physiatrists, rheumatologists and orthopedic surgeons across Fairfax and Loudoun counties. Start with exercise therapy and weight management, which carry the strongest evidence, and add injections or surgery only when needed. The Regenerated.com Virginia arthritis treatment directory lists clinics near the Dulles corridor, is free for patients, and does not sell its listing order.

What is the most effective treatment for osteoarthritis?

Exercise therapy is the most effective first treatment for osteoarthritis, reducing knee pain by roughly 40% across 54 randomized trials in a 2015 Cochrane review. Weight loss adds to that: a 10% loss halved knee pain in the IDEA trial. For end-stage joints, knee or hip replacement is the most reliable option, with about 90-95% of patients reporting significant pain relief. Most people do best by combining approaches rather than relying on one.

Does insurance cover PRP or stem cell injections for osteoarthritis?

Insurance usually does not cover PRP or stem cell injections for osteoarthritis, so most patients pay cash. PRP is not an FDA-approved treatment for osteoarthritis, and the FDA states that no stem cell product is approved for any orthopedic condition. Physical therapy, NSAIDs, cortisone injections and joint replacement are generally covered, and some plans cover hyaluronic acid injections. Ask any clinic for the full price in writing before treatment begins.

Can osteoarthritis be reversed?

Osteoarthritis cannot be reliably reversed with current treatments, but its progression can often be slowed and its symptoms reduced. Exercise, weight loss and well-chosen injections lower pain and protect function, and some MSC studies report cartilage changes on MRI, though that evidence is moderate in quality. Earlier treatment in Kellgren-Lawrence grades 1 to 3 tends to preserve more joint function than waiting until cartilage is gone.

How long do cortisone, PRP and hyaluronic acid injections last?

Cortisone injections relieve osteoarthritis pain for weeks to months, and repeating them every 3 months has been linked to faster cartilage loss. PRP showed benefits at 6 and 12 months in meta-analyses of knee OA trials, mostly in mild to moderate disease. Hyaluronic acid gives a smaller benefit, roughly comparable to NSAIDs. Dextrose prolotherapy gains lasted to 1 year in one randomized trial. Results vary with the joint, the grade and the preparation used.

When should I consider knee or hip replacement for osteoarthritis?

Consider knee or hip replacement when osteoarthritis pain disrupts sleep most nights, limits walking to a few blocks, causes deformity or instability, or persists after 6 to 12 months of well-run conservative care. The decision rests on function and quality of life rather than X-ray appearance alone. Modern implants often last 15 to 25 years, and an orthopedic surgeon can say whether a partial or total replacement fits.

Sources

1. Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol. 2011;23(5):471-478. doi:10.1097/BOR.0b013e328349c2b1. PMID: 21788902 ↩
2. Fransen M, McConnell S, Harmer AR, et al. Exercise for osteoarthritis of the knee: a Cochrane systematic review. Br J Sports Med. 2015;49(24):1554-1557. doi:10.1136/bjsports-2015-095424. PMID: 26405113 ↩
3. Øiestad BE, Juhl CB, Eitzen I, Thorlund JB. Knee extensor muscle weakness is a risk factor for development of knee osteoarthritis. A systematic review and meta-analysis. Osteoarthritis Cartilage. 2015;23(2):171-177. doi:10.1016/j.joca.2014.10.008. PMID: 25450853 ↩
4. Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther. 2013;15(Suppl 3):S2. doi:10.1186/ar4174. PMID: 24267197 ↩
5. Machado GC, Maher CG, Ferreira PH, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350:h1225. doi:10.1136/bmj.h1225. PMID: 25828856 ↩
6. McAlindon TE, LaValley MP, Harvey WF, et al. Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA. 2017;317(19):1967-1975. doi:10.1001/jama.2017.5283. PMID: 28510679 ↩
7. Evans JT, Walker RW, Evans JP, et al. How long does a knee replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up. Lancet. 2019;393(10172):655-663. doi:10.1016/S0140-6736(18)32531-5. PMID: 30782341 ↩
8. Everts P, Onishi K, Jayaram P, et al. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21(20):7794. doi:10.3390/ijms21207794. PMID: 33096812 ↩
9. Belk JW, Kraeutler MJ, Houck DA, et al. Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Am J Sports Med. 2021;49(1):249-260. doi:10.1177/0363546520909397. PMID: 32302218 ↩
10. Riboh JC, Saltzman BM, Yanke AB, et al. Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am J Sports Med. 2016;44(3):792-800. doi:10.1177/0363546515580787. PMID: 25925602 ↩
11. Mancuso P, Raman S, Glynn A, et al. Mesenchymal stem cell therapy for osteoarthritis: the critical role of the cell secretome. Front Bioeng Biotechnol. 2019;7:9. doi:10.3389/fbioe.2019.00009. PMID: 30761299 ↩
12. Ha CW, Park YB, Kim SH, Lee HJ. Intra-articular mesenchymal stem cells in osteoarthritis of the knee: a systematic review of clinical outcomes and evidence of cartilage repair. Arthroscopy. 2019;35(1):277-288.e2. doi:10.1016/j.arthro.2018.07.028. PMID: 30442514 ↩
13. Rabago D, Patterson JJ, Mundt M, et al. Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial. Ann Fam Med. 2013;11(3):229-237. doi:10.1370/afm.1504. PMID: 23690322 ↩
14. Rabago D, Patterson JJ, Mundt M, et al. Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial. Ann Fam Med. 2013;11(3):229-237. doi:10.1370/afm.1504. PMID: 23690322 ↩
15. Altman RD, Manjoo A, Fierlinger A, et al. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015;16:321. doi:10.1186/s12891-015-0775-z. PMID: 26503103 ↩
16. Bellamy N, Campbell J, Robinson V, et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev. 2006;(2):CD005321. doi:10.1002/14651858.CD005321.pub2. PMID: 16625636 ↩
17. Messier SP. Obesity and osteoarthritis: disease genesis and nonpharmacologic weight management. Med Clin North Am. 2009;93(1):145-159. doi:10.1016/j.mcna.2008.09.011. PMID: 19059026 ↩
18. Messier SP, Mihalko SL, Legault C, et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA. 2013;310(12):1263-1273. doi:10.1001/jama.2013.277669. PMID: 24065013 ↩
19. Veronese N, Stubbs B, Noale M, et al. Adherence to a Mediterranean diet is associated with lower prevalence of osteoarthritis: data from the osteoarthritis initiative. Clin Nutr. 2019;38(4):1609-1614. doi:10.1016/j.clnu.2018.08.028. PMID: 30224305 ↩
20. Daily JW, Yang M, Park S. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. J Med Food. 2016;19(8):717-729. doi:10.1089/jmf.2016.3705. PMID: 27533649 ↩
21. García-Coronado JM, Martínez-Olvera L, Elizondo-Omaña RE, et al. Effect of collagen supplementation on osteoarthritis symptoms: a meta-analysis of randomized placebo-controlled trials. Int Orthop. 2019;43(3):531-538. doi:10.1007/s00264-018-4211-5. PMID: 30368550 ↩
22. Brosseau L, Taki J, Deber B, et al. Ottawa Panel evidence-based clinical practice guidelines for the management of osteoarthritis in adults who are obese or overweight. Phys Ther. 2011;91(9):1305-1338. doi:10.2522/ptj.20100104. PMID: 21719637 ↩
23. Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2020;72(2):149-162. doi:10.1002/acr.24131. PMID: 31908149 ↩
24. National Institute for Health and Care Excellence. Osteoarthritis in over 16s: diagnosis and management (NG226). 2022. https://www.nice.org.uk/guidance/ng226 ↩
25. US Food and Drug Administration. Consumer alert on regenerative medicine products including stem cells and exosomes. July 22, 2020. https://www.fda.gov/vaccines-blood-biologics/consumers-biologics/consumer-alert-regenerative-medicine-products-including-stem-cells-and-exosomes ↩

Related Reading

• Exercise for Osteoarthritis: The Best (and Worst) Movements for Joint Health
• Knee Osteoarthritis: Symptoms, Staging, and Treatment Options
• Arthritis in Hands: Types, Symptoms, and Treatments That Preserve Function